Shi Jiageng, Chen Siming, Nie Jiawei, Xiong Kangping, Wang Gang, Qian Kaiyu, Zheng Hang, Wang Xinghuan
Department of Urology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Department of Biological Repositories, Zhongnan Hospital of Wuhan University, Wuhan, China.
BMC Surg. 2025 Jan 9;25(1):14. doi: 10.1186/s12893-025-02758-3.
To evaluate the efficacy of an enhanced recovery after surgery (ERAS) strategy for upper tract urothelial carcinoma (UTUC) patients undergoing laparoscopic radical nephroureterectomy (LRNU).
90 patients who received LRNU at Zhongnan Hospital of Wuhan University between January 2018 and July 2022 were retrospectively analyzed, including 43 in the ERAS group and 47 in the pre-ERAS group. The clinical features, postoperative complications, length of hospital stay (LOS), and hospital expenditures of the two groups were compared via t-test, Mann-Whitney test, and Chi-square test.
In comparison to the pre-ERAS group, the total and postoperative LOS were significantly shorter in the ERAS group [total LOS: 15.0 (13.0-20.0) vs. 21.0 (16.0-26.0), p < 0.001; postoperative LOS: 8.0 (7.0-9.0) vs. 11.0 (9.0-13.0), p < 0.001]. The ERAS group had lower hospitalization costs than that in the pre-ERAS group [56896.40 (48324.30-67498.01) vs. 64249.83 (55574.36-81581.82), p = 0.010]. Additionally, the ERAS group experienced a reduction in postoperative fever incidence (23.4% vs. 4.7%, p = 0.011).
In the realm of LRNU, ERAS protocols are safe and practical for minimizing the LOS while accelerating the rehabilitation of patients undergoing LRNU. This study offers insights for enhancing ERAS protocols for UTUC patients even further.
评估加速康复外科(ERAS)策略对接受腹腔镜根治性肾输尿管切除术(LRNU)的上尿路尿路上皮癌(UTUC)患者的疗效。
回顾性分析2018年1月至2022年7月在武汉大学中南医院接受LRNU的90例患者,其中ERAS组43例,非ERAS组47例。通过t检验、Mann-Whitney检验和卡方检验比较两组的临床特征、术后并发症、住院时间(LOS)和住院费用。
与非ERAS组相比,ERAS组的总住院时间和术后住院时间显著缩短[总住院时间:15.0(13.0 - 20.0)天 vs. 21.0(16.0 - 26.0)天,p < 0.001;术后住院时间:8.0(7.0 - 9.0)天 vs. 11.0(9.0 - 13.0)天,p < 0.001]。ERAS组的住院费用低于非ERAS组[56896.40(48324.30 - 67498.01)元 vs. 64249.83(55574.36 - 81581.82)元,p = 0.010]。此外,ERAS组术后发热发生率降低(23.4% vs. 4.7%,p = 0.011)。
在LRNU领域,ERAS方案安全可行,可缩短住院时间,加速LRNU患者康复。本研究为进一步优化UTUC患者的ERAS方案提供了见解。